1. Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. Issue 2 (28th February 2023) Authors: Yang, Mao; Zhao, Yuhao; Li, Yongsheng; Cui, Xuya; Liu, Fatao; Wu, Wenguang; Wang, Xu-An; Li, Maolan; Liu, Yun; Liu, Yingbin Journal: BMJ open Issue: Volume 13:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Big Data Information under Proportional Hazard Mathematical Model in Analysis of Hepatitis B Virus Infection Data of Patients with Interventional Liver Cancer through Antiviral Therapy of Entecavir. (23rd December 2021) Authors: Zhang, Yichi; Zhao, Shuai; Ding, Han; Song, Xiaoling; Miao, Huijie; Cui, Xuya; Wang, Jian; Han, Bing Other Names: Abdulhay Enas Academic Editor. Journal: Journal of healthcare engineering Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗